Sort
23,748 grants matching “melanoma”
Transcriptional regulation of NC precursor formation
$204,925Carole B Labonne · Northwestern University · R01 · FY2006 · CA
MOUSE CORE
$204,887Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Immune Mechanisms in Choroidal Neovascularization
$204,851Rajendra S Apte · Washington University · K08 · FY2009 · EY
Molecular Diagnosis of Defective Memory Differentiation in Tumor-Specific T Cells
$204,800William Nicholas Haining · Dana-Farber Cancer Inst · R21 · FY2008 · CA
Core 2: RXR Rexinoid Design and Synthesis
$204,798Venkatram Reddy Atigadda · University Of Alabama At Birmingham · P01 · FY2018 · CA
Core 2: RXR Rexinoid Design and Synthesis
$204,798Venkatram Reddy Atigadda · University Of Alabama At Birmingham · P01 · FY2017 · CA
Molecular Engineering of Novel Therapies to Treat Corneal Neovascularization
$204,688Akrit Singh Sodhi · Johns Hopkins University · R21 · FY2024 · EY
SOUTHWEST ONCOLOGY GROUP STUDIES
$204,622University Of Kansas Medical Center · U10 · FY2002 · CA
Molecular Mechanisms of Metastasis Suppression by NM23
$204,613David M Kaetzel · University Of Kentucky · R01 · FY2007 · CA
Mechanistic efforts of chronic alcohol on tumor metastasis and survival
$204,581Gary G Meadows · Washington State University · K05 · FY2008 · AA
Arginine Deprivation: A targeted therapy for Melanoma
$204,525University Of Miami School Of Medicine · R01 · FY2005 · CA
Arginine Deprivation: A targeted therapy for Melanoma
$204,525University Of Miami School Of Medicine · R01 · FY2004 · CA
Imaging and Radiochemistry Core
$204,462Pat B Zanzonico · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
A Phase 0 Trial of Riluzole in Patients with Resectable Stage III or IV Melanoma
$204,380James S Goydos · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2007 · CA
Distinct Modes of Gene Regulation by KDM5
$204,303Julie Secombe · Albert Einstein College Of Medicine · R01 · FY2015 · GM
Core A: Administrative Core
$204,187Marcus W Bosenberg · Yale University · P50 · FY2025 · CA
Elucidating neural crest-like reprogramming in melanoma
$204,171Mizuho Fukunaga-Kalabis · Wistar Institute · R21 · FY2016 · CA
Role of Bim and soluble B7-H1 in monitoring T cell responses to anti-PD-1 therapy in melanoma
$204,138Haidong Dong · Mayo Clinic Rochester · R21 · FY2015 · CA
Molecular Imaging of Novel Immuno-therapy and Targeted Therapies for Malignant...
$204,135Antoni Ribas · University Of California Los Angeles · P50 · FY2013 · CA
Pilot mobile-wearable just-in-time adaptive intervention (JITAI) for sun safety among children
$204,116Jimi Huh · University Of Southern California · R21 · FY2020 · ES
Overcoming Tumor-Intrinsic Therapeutic Resistance to Immunotherapies
$204,106Lewis Zhichang Shi · University Of Alabama At Birmingham · R21 · FY2023 · CA
Schweinfurthins: novel treatment for breast cancer
$204,000Jeffrey D Neighbors · Terpenoid Therapeutics, Inc. · R43 · FY2010 · CA
Multiple Antigen-Engineered DC Immunication & IFNa Boost for Metastatic Melanoma
$203,977Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · CA
Data Safety and Monitoring
$203,966Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2014 · CA
Directing Cytokine Specificity Through Co-translational Carrier Coupling
$203,959Yina Hsing Huang · Dartmouth College · R21 · FY2023 · AI